nonalcoholic fatty liver
Conditions
Interventions
experimental group:Intervention of Shengyu Decoction
control group:placebo
Sponsors
Huadong Hospital
Eligibility
Sex/Gender
All
Age
60 Years to 100 Years
Inclusion criteria
Inclusion criteria: Patients diagnosed with nonalcoholic fatty liver disease.
Exclusion criteria
Exclusion criteria: 1. Complicated with serious primary diseases of cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems; 2. Persons suffering from acute and or chronic infectious diseases; 3. People with allergic constitution or allergy to this medicine ingredients are physically weak; 4. Those who do not meet the inclusion criteria, fail to take medication or complete treatment as prescribed, cannot judge the efficacy or affect the judgment of efficacy or safety with incomplete data; 5. Patients suffering from malignant tumors; 6. Ecg examination of severe arrhythmia; 7. People with mental illness, history of alcohol abuse, drug or other substance abuse; 8. Worsening of stroke, transient ischemic attack, acute coronary syndrome or heart failure requiring hospitalization in the first six months of the introduction observation period; 9. Participate in other clinical trials 3 months prior to randomization; 10. The subject has white blood cells < 3.0 x 10^9/L, or definite anemia (hemoglobin < 80g/L), or platelets < 80x10^9/L, or other blood system diseases; 11. Any other condition or treatment that may make the patient unsuitable for the clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality index;Fibroscan; | — |
Countries
China
Contacts
Public ContactWang Xiaojun
Huadong Hospital
Outcome results
None listed